

Author: Heinig R.
Publisher: Adis International
ISSN: 0312-5963
Source: Clinical Pharmacokinetics, Vol.35, Iss.3, 1998-09, pp. : 191-208
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Tolerability of Nisoldipine Coat-Core in Hypertension
By Klocke R.K.
Clinical Drug Investigation, Vol. 18, Iss. 4, 1999-10 ,pp. :






Bicalutamide: Clinical Pharmacokinetics and Metabolism
Clinical Pharmacokinetics, Vol. 43, Iss. 13, 2004-01 ,pp. :


Clinical Pharmacokinetics of Metformin
Clinical Pharmacokinetics, Vol. 50, Iss. 2, 2011-02 ,pp. :